Impact of Primary Staging with Fibroblast Activation Protein Specific Enzyme Inhibitor (FAPI)-PET/CT on Radio-Oncologic Treatment Planning of Patients with Esophageal Cancer

PURPOSE: Quinoline-based ligands targeting cancer-associated fibroblasts have emerged as promising radiopharmaceuticals in different tumor entities. The aim of this retrospective study was to explore the potential of FAPI-PET/CT in the initial staging of esophageal cancer patients and its usefulness...

Descripción completa

Detalles Bibliográficos
Autores principales: Ristau, J., Giesel, F. L., Haefner, M. F., Staudinger, F., Lindner, T., Merkel, A., Schlittenhardt, J., Kratochwil, C., Choyke, P. L., Herfarth, K., Debus, J., Haberkorn, U., Koerber, S. A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2020
Materias:
Brief Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7666016/
https://www.ncbi.nlm.nih.gov/pubmed/33063132
http://dx.doi.org/10.1007/s11307-020-01548-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7666016/
https://www.ncbi.nlm.nih.gov/pubmed/33063132
http://dx.doi.org/10.1007/s11307-020-01548-y

Ejemplares similares